Summary
Definition
History and exam
Key diagnostic factors
- hemoglobinúria
- Síndrome de Budd-Chiari
- trombose
Other diagnostic factors
- história de anemia aplásica
- fadiga
- anemia
- dor abdominal
- disfagia e odinofagia
- disfunção erétil
- dispneia
- infecções
- diátese hemorrágica
- sinais e sintomas neurológicos
Risk factors
- anemia aplásica/hipoplásica da medula óssea
- mielodisplasia
Diagnostic tests
1st tests to order
- tira reagente para exame de urina
- microscopia da urina
- Hemograma completo
- contagem de reticulócitos
- lactato desidrogenase (LDH) sérico
- bilirrubina não conjugada
- dímero D
Tests to consider
- haptoglobina
- citometria de fluxo para âncora de glicosilfosfatidilinositol ou proteínas ancoradas
- aerolisina fluorescente
- imunofenotipagem
- teste de antiglobulina (Coombs)
- ferro e ferritina séricos
- creatinina sérica e ureia
Treatment algorithm
hemoglobinúria paroxística noturna (HPN) clássica (anemia hemolítica): não gestante
hemoglobinúria paroxística noturna (HPN) clássica (anemia hemolítica): gestante
HPN no contexto de outro distúrbio de medula óssea específico: não gestante
HPN no contexto de outro distúrbio de medula óssea específico: gestante com trombose
HPN no contexto de outro distúrbio de medula óssea específico: gestante sem trombose
HPN subclínica: não gestante
HPN subclínica: gestante
após HPN clínica aguda com trombose: não gestante
Contributors
Authors
Ibrahim Ibrahim, MD
Associate Professor
Internal Medicine
UT Southwestern
Dallas
TX
Disclosures
II declares that he has no competing interests.
Taha Bat, MD
Assistant Professor
Internal Medicine
UT Southwestern
Dallas
TX
Disclosures
TB serves on advisory boards for Alexion Pharmaceuticals and Novartis. He is also the author of an article cited in this topic.
Acknowledgements
Dr Ibrahim and Dr Bat would like to gratefully acknowledge Dr Ilene Ceil Weitz and Dr Wendell F. Rosse, previous contributors to this topic.
Disclosures
WFR serves on advisory boards and educational faculties for Alexion Pharmaceuticals. ICW receives speaker honoraria from and undertakes consultancy for Alexion Pharmaceuticals.
Peer reviewers
David Dingli, MD, PhD
Associate Professor of Medicine
Mayo Clinic
Rochester
MN
Disclosures
DD declares that he has no competing interests.
Panayiotis D. Ziakas, MD, MSc, PhD
Department of Pathophysiology
Medical School
University of Athens
Athens
Greece
Disclosures
PDZ declares that he has no competing interests.
Peer reviewer acknowledgements
BMJ Best Practice topics are updated on a rolling basis in line with developments in evidence and guidance. The peer reviewers listed here have reviewed the content at least once during the history of the topic.
Disclosures
Peer reviewer affiliations and disclosures pertain to the time of the review.
References
Key articles
Parker CJ. Update on the diagnosis and management of paroxysmal nocturnal hemoglobinuria. ASH Education Book 2016;2016(1):208-16.Full text Abstract
National Organization for Rare Disorders. NORD rare disease report: paroxysmal nocturnal hemoglobinuria. May 2024 [internet publication].Full text
Dezern AE, Borowitz MJ. ICCS/ESCCA Consensus Guidelines to detect GPI‐deficient cells in Paroxysmal Nocturnal Hemoglobinuria (PNH) and related Disorders Part 1 – Clinical Utility. Cytometry B Clin Cytom. 2018;94(1):16-22.Full text Abstract
Reference articles
A full list of sources referenced in this topic is available to users with access to all of BMJ Best Practice.
Differentials
- Anemia hemolítica autoimune por anticorpos a quente (warm antibody type)
- Anemia hemolítica microangiopática
- Hemoglobinúria paroxística ao frio
More DifferentialsGuidelines
- Paroxysmal nocturnal hemoglobinuria
- Consensus guidelines to detect GPI‐deficient cells in paroxysmal nocturnal hemoglobinuria (PNH) and related disorders: Part 1 – clinical utility
More GuidelinesFolletos para el paciente
Pressão alta: o que é?
Pressão alta: quais tratamentos funcionam?
Más Folletos para el pacienteInicie sesión o suscríbase para acceder a todo el BMJ Best Practice
El uso de este contenido está sujeto a nuestra cláusula de exención de responsabilidad